Lv6
1815 积分 2021-07-08 加入
Chronotherapy with immune checkpoint inhibitors: The knowns, the unknowns, and the contested
1个月前
已完结
Tumor spatial transcriptomics and potential mechanisms of intrinsic resistance to HER2-directed therapy
1个月前
已关闭
Super-silencer perturbation by EZH2 and REST inhibition leads to large loss of chromatin interactions and reduction in cancer growth
1个月前
已完结
Dual Targeting of CDK4/6 and BCL2 Pathways Augments Tumor Response in Estrogen Receptor-Positive Breast Cancer
1个月前
已完结
TRMT6-mediated tRNA m1A modification acts as a translational checkpoint of histone synthesis and facilitates colorectal cancer progression
1个月前
已完结
Independent Drug Action in Combination Therapy: Implications for Precision Oncology
1个月前
已完结
Effective drug combinations in breast, colon and pancreatic cancer cells
1个月前
已完结
Targeting PLK1 overcomes T-DM1 resistance via CDK1-dependent phosphorylation and inactivation of Bcl-2/xL in HER2-positive breast cancer
1个月前
已完结
HGF/c-MET pathway in cancer: from molecular characterization to clinical evidence
1个月前
已完结
Forging New Pathways in Oncology: Strategic Insights from the 17th Annual Frontiers in Cancer Science Conference
2个月前
已完结
皖公网安备34019202002308
